Jesper Pallesen

Title: Jesper Pallesen: Innovator in Coronavirus Research

Introduction

Jesper Pallesen is a notable inventor based in La Jolla, CA (US). He has made significant contributions to the field of coronavirus research, holding 2 patents that focus on innovative approaches to combatting viral infections. His work is particularly relevant in the context of the ongoing global health challenges posed by coronaviruses.

Latest Patents

Pallesen's latest patents include groundbreaking developments in prefusion coronavirus spike proteins. These patents disclose coronavirus S ectodomain trimers that are stabilized in a prefusion conformation, along with nucleic acid molecules and vectors encoding these proteins. The methods outlined in these patents detail how these ectodomain trimers and nucleic acid molecules can be utilized to generate an immune response to coronavirus in a subject. Furthermore, they describe the administration of therapeutically effective amounts of these components as a method for treating or preventing coronavirus infection.

Career Highlights

Throughout his career, Jesper Pallesen has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and The Scripps Research Institute. His experience in these institutions has allowed him to contribute significantly to scientific research and innovation.

Collaborations

Pallesen has collaborated with esteemed colleagues in the field, including Barney S. Graham and Jason Scott McLellan. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Jesper Pallesen's work in the field of coronavirus research exemplifies the importance of innovation in addressing global health issues. His patents and career achievements highlight his commitment to advancing scientific knowledge and developing effective solutions for viral infections.